Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACM-1 in Ophthalmological Neovascular Diseases
NCT02448732Phase 1Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Dec 2014
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ACM-1 in neovascular eye disease, sponsored by Sun Yat-sen University. Primary endpoint: Fluorescence Fundus Angiography at 6 months. Status: unknown.
02
Drugs
ACM-1
03
Conditions
neovascular eye disease
Beyond the preview
Go deeper on NCT02448732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02448732.